Both of these GLP-1 drugs were originally designed for diabetes, but their benefits keep expanding — KSTP health expert Dr.
More than 69.2 million FDA-approved weight-loss prescriptions were dispensed in the U.S. from July 2017 through February 2024 ...
My parents are both retired medical professionals who are in their early 70s. My father has diabetes that he manages with medication, and he also has a history of recurrent prostate cancer. My mother ...
My parents are both retired medical professionals who are in their early 70s. My father has diabetes that he manages with ...
Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...
Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions such as ...
GLP-1 medications like Ozempic, Wegovy, and Mounjaro are linked to reduced risks of dementia, heart failure, and severe ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat substance abuse disorders, psychosis, infections, cancer, and dementia.
In fact, the updated recommendations come as a growing number of women and men take prescription weight loss medications such ... ingredient in Eli Lilly’s Zepbound. A recent study found ...
(Reuters) -Eli Lilly's stock tumbled 8% on Tuesday after it forecast fourth-quarter sales of weight-loss drug Zepbound below Wall Street estimates, marking the second time sales have disappointed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback